Nexalin Backing Senate Bill to Expand Medicare AI Device Reimbursement
Nexalin supports bipartisan Health Tech Investment Act to expand Medicare reimbursement for FDA-approved AI medical devices, aiding innovation in mental health treatment.
Senate Bill Proposes Clear Medicare Payment Pathway for AI Medical Devices
The Health Tech Investment Act aims to create a consistent Medicare payment system for FDA-approved AI medical devices, enhancing patient access and improving healthcare outcomes.